CH598230A5 - - Google Patents

Info

Publication number
CH598230A5
CH598230A5 CH155277A CH155277A CH598230A5 CH 598230 A5 CH598230 A5 CH 598230A5 CH 155277 A CH155277 A CH 155277A CH 155277 A CH155277 A CH 155277A CH 598230 A5 CH598230 A5 CH 598230A5
Authority
CH
Switzerland
Application number
CH155277A
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of CH598230A5 publication Critical patent/CH598230A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH155277A 1976-02-18 1977-02-09 CH598230A5 (US06350818-20020226-C00016.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6430/76A GB1525995A (en) 1976-02-18 1976-02-18 Aminopyrimidine salt

Publications (1)

Publication Number Publication Date
CH598230A5 true CH598230A5 (US06350818-20020226-C00016.png) 1978-04-28

Family

ID=9814350

Family Applications (1)

Application Number Title Priority Date Filing Date
CH155277A CH598230A5 (US06350818-20020226-C00016.png) 1976-02-18 1977-02-09

Country Status (21)

Country Link
US (1) US4073895A (US06350818-20020226-C00016.png)
JP (1) JPS5928548B2 (US06350818-20020226-C00016.png)
AR (1) AR215879A1 (US06350818-20020226-C00016.png)
AT (1) AT353277B (US06350818-20020226-C00016.png)
AU (1) AU507897B2 (US06350818-20020226-C00016.png)
BE (1) BE851255A (US06350818-20020226-C00016.png)
CA (1) CA1064495A (US06350818-20020226-C00016.png)
CH (1) CH598230A5 (US06350818-20020226-C00016.png)
DE (1) DE2707095C3 (US06350818-20020226-C00016.png)
DK (1) DK142363B (US06350818-20020226-C00016.png)
ES (1) ES455945A1 (US06350818-20020226-C00016.png)
FR (2) FR2341315A1 (US06350818-20020226-C00016.png)
GB (1) GB1525995A (US06350818-20020226-C00016.png)
HK (1) HK59079A (US06350818-20020226-C00016.png)
IN (1) IN145714B (US06350818-20020226-C00016.png)
MX (1) MX4494E (US06350818-20020226-C00016.png)
MY (1) MY8000069A (US06350818-20020226-C00016.png)
NL (1) NL167962C (US06350818-20020226-C00016.png)
NZ (1) NZ183234A (US06350818-20020226-C00016.png)
PT (1) PT66191B (US06350818-20020226-C00016.png)
ZA (1) ZA77570B (US06350818-20020226-C00016.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL57352A0 (en) * 1978-06-16 1979-09-30 Expansia Sa Preparation of 2-isopropylamino-pyrimidine
IN153791B (US06350818-20020226-C00016.png) * 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
BE882836A (fr) * 1979-05-15 1980-08-18 Soc D Etudes Prod Chimique Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique
BE885851A (fr) * 1979-11-02 1981-02-16 Soc D Etudes Prod Chimique Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie
US4416885A (en) * 1979-11-02 1983-11-22 Huve Pierre M Use of isopropylaminopyrimidine in the chemotherapy of muscular dystrophy, myopathy and myotonia
JPS56152059A (en) * 1980-04-25 1981-11-25 Hitachi Ltd Program debugging system
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4868161A (en) * 1984-06-29 1989-09-19 City Of Hope Method for promoting nerve regeneration
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
WO2011053737A2 (en) 2009-11-02 2011-05-05 Saes Smart Materials Ni-Ti SEMI-FINISHED PRODUCTS AND RELATED METHODS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6235815D0 (pt) * 1961-01-23 1973-05-24 Parke Davis & Co Processo para a producao de compostos de pirimidina
BE788648A (fr) * 1971-10-09 1973-01-02 Soc D Etudes Prod Chimique Derives de l'isopropylamino pyrimidine, leur preparation leur composition et leur utilisation therapeutique

Also Published As

Publication number Publication date
JPS52100477A (en) 1977-08-23
AT353277B (de) 1979-11-12
DK142363B (da) 1980-10-20
AU507897B2 (en) 1980-02-28
MY8000069A (en) 1980-12-31
DE2707095C3 (de) 1979-04-12
AU2202077A (en) 1978-08-17
ZA77570B (en) 1977-12-28
DK142363C (US06350818-20020226-C00016.png) 1981-03-23
US4073895A (en) 1978-02-14
GB1525995A (en) 1978-09-27
PT66191B (pt) 1978-07-11
IN145714B (US06350818-20020226-C00016.png) 1985-01-05
HK59079A (en) 1979-08-31
NL167962C (nl) 1982-02-16
FR2341571B1 (US06350818-20020226-C00016.png) 1980-03-14
AR215879A1 (es) 1979-11-15
FR2341315A1 (fr) 1977-09-16
JPS5928548B2 (ja) 1984-07-13
DK68177A (US06350818-20020226-C00016.png) 1977-08-19
ES455945A1 (es) 1978-01-16
DE2707095B2 (US06350818-20020226-C00016.png) 1978-08-17
FR2341315B1 (US06350818-20020226-C00016.png) 1978-11-17
MX4494E (es) 1982-05-21
ATA96677A (de) 1979-04-15
NL7701522A (nl) 1977-08-22
NL167962B (nl) 1981-09-16
DE2707095A1 (de) 1977-08-25
FR2341571A1 (fr) 1977-09-16
BE851255A (fr) 1977-05-31
CA1064495A (en) 1979-10-16
PT66191A (pt) 1977-03-01
NZ183234A (en) 1978-11-13

Similar Documents

Publication Publication Date Title
DK142363C (US06350818-20020226-C00016.png)
JPS543918B2 (US06350818-20020226-C00016.png)
JPS5731725B2 (US06350818-20020226-C00016.png)
JPS5321740U (US06350818-20020226-C00016.png)
JPS5352461U (US06350818-20020226-C00016.png)
JPS5390940U (US06350818-20020226-C00016.png)
JPS5518842Y2 (US06350818-20020226-C00016.png)
JPS52113211U (US06350818-20020226-C00016.png)
JPS5324198U (US06350818-20020226-C00016.png)
JPS52109399U (US06350818-20020226-C00016.png)
JPS5311160U (US06350818-20020226-C00016.png)
JPS561106Y2 (US06350818-20020226-C00016.png)
JPS5424512Y2 (US06350818-20020226-C00016.png)
JPS5217269B1 (US06350818-20020226-C00016.png)
JPS555622B2 (US06350818-20020226-C00016.png)
JPS52120418U (US06350818-20020226-C00016.png)
JPS5346768U (US06350818-20020226-C00016.png)
JPS5381365U (US06350818-20020226-C00016.png)
JPS5359175U (US06350818-20020226-C00016.png)
JPS52166385U (US06350818-20020226-C00016.png)
JPS5358840U (US06350818-20020226-C00016.png)
CH599828A5 (US06350818-20020226-C00016.png)
CH598518A5 (US06350818-20020226-C00016.png)
CH608858A5 (US06350818-20020226-C00016.png)
CH597877A5 (US06350818-20020226-C00016.png)

Legal Events

Date Code Title Description
PL Patent ceased